Medicare Enrolled
Dr. Charles Bane, MD
Hematology & Oncology · Dayton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bane
Dr. Charles Bane is a hematology & oncology specialist in Dayton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bane performed 58,306 Medicare services across 1,621 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bane received a total of $9,903 from 78 pharmaceutical and/or device companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in OH
$9,903 industry payments
Medicare Practice Summary
Medicare Utilization ↗58,306
Medicare services
Top 8% in OH for hematology & oncology
1,621
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,915 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
15,750 | $1 | $2 |
| Pembrolizumab injection (Keytruda) | 9,000 | $43 | $99 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
8,550 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
5,750 | $2 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,900 | $0 | $0 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,700 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $37 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,350 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
970 | $88 | $207 |
| Anti-nausea injection (Aloxi/palonosetron) | 910 | $1 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
368 | $53 | $140 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
322 | $129 | $281 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
209 | $95 | $403 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
190 | $10 | $45 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
184 | $11 | $64 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
158 | $92 | $156 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
114 | $6 | $50 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
98 | $21 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
87 | $45 | $181 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
79 | $47 | $198 |
| New patient office visit, complex (60-74 min) | 51 | $152 | $402 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
49 | $21 | $92 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
41 | $41 | $166 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $1 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
30 | $742 | $2,196 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
27 | $209 | $448 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
23 | $86 | $470 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
23 | $77 | $254 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $627 | $800 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $399 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
17 | $59 | $375 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $110 | $320 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
11 | $168 | $484 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.8% high complexity
68.8% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,903
Total received (2018-2024)
Avg $1,415/year across 7 years
Top 28% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
522
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,831 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,061
2023
$3,142
2022
$1,364
2021
$441
2020
$172
2019
$1,127
2018
$596
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$376
Merck Sharp & Dohme LLC
$360
Novartis Pharmaceuticals Corporation
$253
Janssen Biotech, Inc.
$171
Genentech USA, Inc.
$154
AstraZeneca Pharmaceuticals LP
$137
Daiichi Sankyo Inc.
$103
PFIZER INC.
$102
Lilly USA, LLC
$97
Incyte Corporation
$92
TerSera Therapeutics LLC
$83
Bayer Healthcare Pharmaceuticals Inc.
$79
GlaxoSmithKline, LLC.
$79
Stemline Therapeutics Inc.
$64
Celgene Corporation
$63
Regeneron Healthcare Solutions, Inc.
$61
Aveo Pharmaceuticals, Inc.
$59
SOBI, INC
$56
ADC Therapeutics America, Inc.
$49
Cardinal Health 110 LLC
$49
Genmab U.S., Inc.
$47
Kyowa Kirin, Inc.
$41
Ipsen Biopharmaceuticals, Inc
$38
Astellas Pharma US Inc
$37
PharmaEssentia USA Corporation
$37
Gilead Sciences, Inc.
$35
SERVIER PHARMACEUTICALS LLC
$34
ARRAY BIOPHARMA INC
$30
E.R. Squibb & Sons, L.L.C.
$30
Kite Pharma, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$22
Adaptive Biotechnologies Corporation
$20
Eisai Inc.
$19
TAIHO ONCOLOGY, INC.
$18
Karyopharm Therapeutics Inc.
$18
Legend Biotech USA Inc.
$17
Immunocore Limited
$17
Dendreon Pharmaceuticals LLC
$16
Myriad Genetic Laboratories, Inc.
$16
Sirtex Medical Inc
$16
Exelixis Inc.
$15
Alexion Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 32.3% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$810
Novartis Pharmaceuticals Corporation
$757
Janssen Biotech, Inc.
$509
E.R. Squibb & Sons, L.L.C.
$445
Pharmacyclics LLC, An AbbVie Company
$407
AstraZeneca Pharmaceuticals LP
$399
ABBVIE INC.
$376
Daiichi Sankyo Inc.
$373
PFIZER INC.
$369
Genentech USA, Inc.
$360
Incyte Corporation
$313
GENZYME CORPORATION
$263
Celgene Corporation
$234
Lilly USA, LLC
$228
Amgen Inc.
$225
Astellas Pharma US Inc
$218
TerSera Therapeutics LLC
$210
Takeda Pharmaceuticals U.S.A., Inc.
$165
Regeneron Healthcare Solutions, Inc.
$155
Bayer HealthCare Pharmaceuticals Inc.
$146
Ipsen Biopharmaceuticals, Inc
$144
Varian Medical Systems, Inc.
$141
Bayer Healthcare Pharmaceuticals Inc.
$138
Gilead Sciences, Inc.
$132
BeiGene USA, Inc.
$115
GlaxoSmithKline, LLC.
$113
Pharmacyclics LLC, an AbbVie Company
$100
Genmab U.S., Inc.
$95
Merck Sharp & Dohme Corporation
$84
Stemline Therapeutics Inc.
$83
Foundation Medicine, Inc.
$83
PharmaEssentia USA Corporation
$81
ADC Therapeutics America, Inc.
$79
Seagen Inc.
$79
Kyowa Kirin, Inc.
$73
JAZZ PHARMACEUTICALS INC.
$67
EISAI INC.
$65
ARRAY BIOPHARMA INC
$64
Aveo Pharmaceuticals, Inc.
$59
Eisai Inc.
$58
Adaptive Biotechnologies Corporation
$57
SERVIER PHARMACEUTICALS LLC
$57
SOBI, INC
$56
Rigel Pharmaceuticals, Inc.
$55
Karyopharm Therapeutics Inc.
$52
Cardinal Health 110 LLC
$49
Blueprint Medicines Corporation
$47
Array BioPharma Inc.
$43
Apellis Pharmaceuticals, Inc.
$40
Kite Pharma, Inc.
$40
Jazz Pharmaceuticals Inc.
$34
Aurobindo Pharma USA, Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
AbbVie Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Puma Biotechnology, Inc.
$28
Clovis Oncology, Inc.
$26
Exelixis Inc.
$26
Cumberland Pharmaceuticals, Inc.
$25
MorphoSys, US Inc.
$25
Janssen Scientific Affairs, LLC
$24
RECORDATI_RARE_DISEASES_INC.
$21
Alnylam Pharmaceuticals Inc.
$21
EUSA Pharma (US) LLC
$20
Deciphera Pharmaceuticals Inc.
$20
TAIHO ONCOLOGY, INC.
$18
Taiho Oncology, Inc.
$17
Legend Biotech USA Inc.
$17
Immunocore Limited
$17
Dendreon Pharmaceuticals LLC
$16
Agios Pharmaceuticals, Inc.
$16
Myriad Genetic Laboratories, Inc.
$16
Sirtex Medical Inc
$16
G1 Therapeutics, Inc.
$15
Heron Therapeutics, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Teva Pharmaceuticals USA, Inc.
$14
TESARO, Inc.
$11
Top 3 companies account for 21.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · BENDEKA · BESREMI · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CREON · CYRAMZA · DARZALEX · ELIQUIS · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MVASI · MYRISK · Marqibo · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SYLVANT · SYNAGIS · Stivarga · Sylvant · TABRECTA · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Venclexta · Voranigo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
39
Per 100K population
7.3
County median income
$64,403
Nearest hospital
KETTERING HEALTH DAYTON
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bane is a mixed practice specialist, with above-average Medicare volume (top 8% in OH), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bane experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Bane performed 15,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bane receive payments from pharmaceutical companies?
Yes. Dr. Bane received a total of $9,903 from 78 companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bane's costs compare to other hematology & oncology specialists in Dayton?
Dr. Bane's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Dayton
Browse hematology & oncology specialists in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology